View Cart (0 items)


FDA reviewer slams study that questions generic drug quality

March 28, 2014
A senior official with the U.S. FDA has slammed research that suggests many heart drugs produced outside the U.S. contain impurities.
Read More

Horizon Pharma buys Irish drug maker Vidara

March 26, 2014
Illinois-based Horizon Pharma Inc. announced last week it was taking over Irish Vidara Therapeutics International Ltd. in a reverse merger, moving its headquarters to Dublin.
Read More

Pfizer seeks to ban sales of generic Viagra in US

March 24, 2014
U.S. pharmaceutical corporation Pfizer has filed a lawsuit against Indian drug maker Torrent Pharmaceuticals Ltd. in an effort to prevent sales of a generic version of Viagra.
Read More

Canada's drug spending growth slowed by generics

March 19, 2014
Market share is increasing for generics drugs, which are typically much cheaper than branded and patented drugs.
Read More

Many generic drugs fail to serve their purpose, doctors warn

March 4, 2014
Doctors and researchers have criticized the U.S. Food and Drug Administration (FDA) for failing to control the effectiveness of the vast majority of pharmaceutical products sold in the United States.
Read More

Endo Pharmaceuticals settles lawsuit over unlawful marketing

February 26, 2014
Pharmaceutical companies Endo Pharmaceuticals and Endo Health Solutions will have to pay $192.7 million to resolve criminal and civil charges related to their marketing policy for the product Lidoderm.
Read More

AstraZeneca, Merck gain share on Glaxo's asthma treatment drug

February 18, 2014
Competition on the U.S. pharmaceutical market has never been more fierce. Generic drugs are taking decisive steps onto the market, gaining a bigger share wherever they are allowed.
Read More

Plastics, polymers to dominate global pharmaceutical packaging market

February 11, 2014
Over the years through 2018, the global pharmaceutical packaging market is predicted to reach $78.79 billion, with Europe, Japan and the U.S. accounting for about 70% of the entire market.
Read More

Mexico's Neolpharma opens R&D facility in Puerto Rico

February 5, 2014
The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

January 29, 2014
The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More